Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
7.66
0.36 (4.93%)
At close: Aug 15, 2025, 3:59 PM
7.67
0.13%
After-hours: Aug 15, 2025, 07:25 PM EDT
Xeris Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.93M | -9.22M | -5.11M | -15.74M | -15.01M | -18.98M | -13.39M | -12.19M | -19.84M | -16.83M | -12.93M | -21.83M | -26.18M | -33.71M | -50.79M | -26.01M | -27.52M | -18.41M |
Depreciation & Amortization | 2.92M | 3.14M | 3.13M | 2.68M | 3.15M | 3.21M | 3.26M | 3.36M | 3.36M | 3.18M | 3.5M | 3.07M | 3.06M | 3.03M | 899K | 323K | 320K | 337K |
Stock-Based Compensation | 5.01M | 4.44M | 3.6M | 6.77M | 4.23M | 3.77M | 2.77M | 2.46M | 2.93M | 2.56M | 2.77M | 2.94M | 3.15M | 3.3M | 2.74M | 3.67M | 2.51M | 2.46M |
Other Working Capital | 3.77M | -3.77M | n/a | 7.11M | 5.5M | -613K | 12.81M | 6.89M | 7.16M | -16.95M | 5.12M | 647K | 1.56M | -20.3M | 14.59M | 2.6M | 7.63M | -4.83M |
Other Non-Cash Items | -5.21M | 844K | 834K | -7.71M | 19.33M | 12.24M | -2.93M | -361K | -222K | -811K | -6.45M | 320K | 4.79M | 3.19M | 234K | 235K | 241K | 251K |
Deferred Income Tax | n/a | n/a | n/a | -3.32M | 749K | 307K | -1.25M | 2.84M | -416K | -382K | n/a | n/a | n/a | n/a | 853K | -8K | 136K | 134K |
Change in Working Capital | 9.24M | -9.24M | -474K | 9.02M | -3.39M | -5.63M | 17.83M | -10.71M | 445K | -13.86M | -3.01M | -2.5M | -5.43M | -24.21M | 17.11M | -817K | 4.28M | -8.73M |
Operating Cash Flow | 10.03M | -10.03M | 1.98M | -8.3M | -10.35M | -20.3M | 6.29M | -14.61M | -13.74M | -26.14M | -16.12M | -17.75M | -20.61M | -48.41M | -28.95M | -22.61M | -20.02M | -23.96M |
Capital Expenditures | 13K | -13K | -220K | -87K | -397K | -164K | -132K | -345K | -1.55M | -238K | -132K | -176K | -216K | 16K | -131K | -307K | -218K | -429K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | 16K | 38.47M | 307K | 218K | 429K |
Purchase of Investments | n/a | n/a | n/a | -5M | -5M | -24.49M | n/a | n/a | n/a | -43.74M | n/a | n/a | 16K | n/a | -12.24M | -10.64M | -12.23M | -7.92M |
Sales Maturities Of Investments | n/a | n/a | 10.24M | 15M | 10M | 5M | 15M | 15M | 10M | n/a | 9.3M | 6.88M | 12.1M | 6.7M | 10.5M | 29.45M | 29M | 34.65M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 5M | -19.49M | 15M | 15M | 10M | -43.74M | n/a | 6.88M | -16K | 6.72M | -1.74M | -307K | -218K | -429K |
Investing Cash Flow | 13K | -13K | 10.02M | 9.91M | 4.6M | -19.65M | 14.87M | 14.65M | 8.45M | -43.98M | 9.17M | 6.71M | 11.87M | 6.72M | 36.6M | 18.5M | 16.56M | 26.3M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 38.17M | n/a | n/a | n/a | n/a | 48.92M | n/a | n/a | 53.8M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 8M | -8M | -166K | -83K | -51K | -3.43M | -49K | -72K | -25K | -863K | -21K | -28K | -3K | -416K | -169K | n/a | n/a | -365K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.86M | 4.86M | 564K | n/a | 710K | 459K | -1.19M | n/a | 581K | n/a | 258K | -159K | 313K | 24.81M | 294K | 1K | 460K | 26K |
Financial Cash Flow | 3.14M | -3.14M | 398K | -83K | 659K | 35.19M | -49K | -72K | 556K | -863K | 49.16M | -187K | 310K | 78.19M | 125K | 1K | 460K | 26.66M |
Net Cash Flow | n/a | -13.18M | 12.39M | 1.53M | -5.09M | -4.76M | 21.31M | -27K | -4.74M | -70.98M | 42.2M | -11.23M | -8.43M | 36.5M | 7.78M | -4.11M | -3M | 29.01M |
Free Cash Flow | 10.04M | -10.04M | 1.75M | -8.39M | -10.74M | -20.47M | 6.15M | -14.96M | -15.29M | -26.38M | -16.25M | -17.93M | -20.82M | -48.39M | -29.08M | -22.92M | -20.24M | -24.39M |